Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.4003
+0.0063 (1.60%)
At close: May 15, 2026, 4:00 PM EDT
0.4000
-0.0003 (-0.07%)
After-hours: May 15, 2026, 6:06 PM EDT
Silo Pharma Market Cap
Silo Pharma has a market cap or net worth of $6.51 million as of May 15, 2026. Its market cap has increased by 91.52% in one year.
Market Cap
6.51M
Enterprise Value
-509.91K
1-Year Change
91.52%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since September 27, 2022, Silo Pharma's market cap has decreased from $13.10M to $6.51M, a decrease of -50.29%. That is a compound annual growth rate of -17.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 6.40M | 42.22% |
| Dec 31, 2025 | 4.50M | 12.50% |
| Dec 31, 2024 | 4.00M | -11.11% |
| Dec 29, 2023 | 4.50M | -57.14% |
| Dec 30, 2022 | 10.50M | -19.85% |
| Sep 27, 2022 | 13.10M | - |
View and export this data all the way back to 2022. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Processa Pharmaceuticals | 6.78M |
| TransCode Therapeutics | 6.62M |
| Immuron | 6.60M |
| Aptorum Group | 6.52M |
| XTL Biopharmaceuticals | 6.50M |
| Purple Biotech | 6.37M |
| MetaVia | 6.20M |
| FibroBiologics | 6.10M |